Asian Journal of Pharmaceutical Sciences

Papers
(The H4-Index of Asian Journal of Pharmaceutical Sciences is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Artificial polysaccharide-binding protein mediates co-assembly of nanodrug and probiotics against drug-resistant infectious enteritis153
Ginseng-derived exosome-like nanovesicles protect against liver fibrosis by regulating TIMP2 pathways and gut dysbiosis100
Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment87
CaCO3-encircled hollow CuS nanovehicles to suppress cervical cancer through enhanced calcium overload-triggered mitochondria damage74
Spatiotemporal transformable nano-assembly for on-demand drug delivery to enhance anti-tumor immunotherapy53
Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges48
Charge adaptive phytochemical-based nanoparticles for eradication of methicillin-resistant staphylococcus aureus biofilms36
Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities36
Hyaluronic acid conjugates with controlled oleic acid substitution as new nanomaterials for improving ocular co-delivery of cyclosporine A and oleic acid33
Bone mesenchymal stem cell-derived exosomes involved co-delivery and synergism effect with icariin via mussel-inspired multifunctional hydrogel for cartilage protection33
Penetrative biomimetic nanovehicle boosts immunotherapy in triple-negative breast cancer via SOS1 blockade33
Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment31
Cell membrane-coated mRNA nanoparticles for enhanced delivery to dendritic cells and immunotherapy29
Improving treatment for Parkinson's disease: Harnessing photothermal and phagocytosis-driven delivery of levodopa nanocarriers across the blood-brain barrier28
Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography27
Targeted delivery of glucocerebrosidase to lysosomes: The LYSOTAC (LYSOsome-TArgeting Chimera) technology27
pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo-photodynamic therapy of melanoma27
Publisher's Note24
Development and preclinical evaluation of a novel FGFR3-targeted antibody-drug conjugate in bladder cancer24
Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery24
Advanced strategies of covalent organic framework nanomedicines in targeting and overcoming biological barriers23
Blockade of neutrophil recruitment to tumor sites based on sialic acid-modified nanoplatforms enhances the efficacy of checkpoint blockade immunotherapy23
Neutrophil-targeted liposomal platform: A shift in novel approach for early detection and treatment of cancer metastasis22
Optimize the combination regimen of Trastuzumab and Nab-paclitaxel in HER2-positive tumors via modulating Caveolin-1 expression by lovastatin22
Electrically conductive “SMART” hydrogels for on-demand drug delivery22
Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases22
Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application22
Preliminary delivery efficiency prediction of nanotherapeutics into crucial cell populations in bone marrow niche22
0.73594903945923